FUJIFILM HEALTHCARE FRANCE SAS : revenue, balance sheet and financial ratios

FUJIFILM HEALTHCARE FRANCE SAS is a French company founded 29 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in ASNIERES-SUR-SEINE (92600), this company of category ETI shows in 2025 a revenue of 122.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - FUJIFILM HEALTHCARE FRANCE SAS (SIREN 408663441)
Indicator 2025 2024 2021 2020 2019 2018 2017 2016 2015
Revenue 122 091 045 € 20 796 145 € 25 148 845 € 24 703 704 € 23 279 588 € 19 921 393 € 23 562 414 € 31 495 504 € 33 064 694 €
Net income 2 339 981 € 208 248 € 274 692 € 385 778 € 4 118 € 319 365 € 60 719 € 287 155 € -1 437 819 €
EBITDA 2 139 077 € -25 704 € -723 985 € -1 784 541 € 182 268 € -1 528 062 € -1 623 968 € -226 869 € -3 768 391 €
Net margin 1.9% 1.0% 1.1% 1.6% 0.0% 1.6% 0.3% 0.9% -4.3%

Revenue and income statement

In 2025, FUJIFILM HEALTHCARE FRANCE SAS achieves revenue of 122.1 M€. Over the period 2015-2025, the company shows strong growth with a CAGR (compound annual growth rate) of +14.0%. Vs 2024, growth of +487% (20.8 M€ -> 122.1 M€). After deducting consumption (66.8 M€), gross margin stands at 55.3 M€, i.e. a rate of 45%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 2.1 M€, representing 1.8% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 2.3 M€, i.e. 1.9% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2025) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

122 091 045 €

Gross margin (2025) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

55 251 142 €

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

2 139 077 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

4 395 184 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

2 339 981 €

EBITDA margin (2025) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

1.8%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 33%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 2.8% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.215%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

33.428%

Cash flow / Revenue (2025) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

2.82%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.02

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

33.2%

Solvency indicators evolution
FUJIFILM HEALTHCARE FRANCE SAS

Sector positioning

Debt ratio
0.21 2025
2021
2024
2025
Q1: 0.0
Med: 3.67
Q3: 28.55
Good

In 2025, the debt ratio of FUJIFILM HEALTHCARE FRANC... (0.21) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
33.43% 2025
2021
2024
2025
Q1: 26.28%
Med: 43.48%
Q3: 62.04%
Average +10 pts over 3 years

In 2025, the financial autonomy of FUJIFILM HEALTHCARE FRANC... (33.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
0.02 years 2025
2021
2024
2025
Q1: 0.0 years
Med: 0.0 years
Q3: 0.67 years
Average +26 pts over 3 years

In 2025, the repayment capacity of FUJIFILM HEALTHCARE FRANC... (0.02) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 143.38. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.3x. Danger: operating income does not cover interest charges, unsustainable situation.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

143.377

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.303

Liquidity indicators evolution
FUJIFILM HEALTHCARE FRANCE SAS

Sector positioning

Liquidity ratio
143.38 2025
2021
2024
2025
Q1: 147.44
Med: 215.05
Q3: 310.05
Watch -7 pts over 3 years

In 2025, the liquidity ratio of FUJIFILM HEALTHCARE FRANC... (143.38) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
0.3x 2025
2021
2024
2025
Q1: 0.0x
Med: 0.36x
Q3: 5.44x
Average +21 pts over 3 years

In 2025, the interest coverage of FUJIFILM HEALTHCARE FRANC... (0.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 65 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 95 days. Favorable situation: supplier credit is longer than customer credit by 30 days. Inventory turnover is 3 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 8 days of revenue, i.e. 2.8 M€ to permanently finance. Notable WCR improvement over the period (-83%), freeing up cash.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

2 775 129 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

65 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

95 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

3 j

WCR in days of revenue (2025) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

8 j

WCR and payment terms evolution
FUJIFILM HEALTHCARE FRANCE SAS

Positioning of FUJIFILM HEALTHCARE FRANCE SAS in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of FUJIFILM HEALTHCARE FRANCE SAS is estimated at 8 937 978 € (range 4 732 345€ - 27 772 444€). With an EBITDA of 2 139 077€, the sector multiple of 0.7x is applied. The price/revenue ratio is 0.21x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
124 transactions
4732k€ 8937k€ 27772k€
8 937 978 € Range: 4 732 345€ - 27 772 444€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
2 139 077 € × 0.7x
Estimation 1 505 665 €
711 781€ - 5 480 069€
Revenue Multiple 30%
122 091 045 € × 0.21x
Estimation 26 002 267 €
14 100 413€ - 78 761 295€
Net Income Multiple 20%
2 339 981 € × 0.8x
Estimation 1 922 331 €
731 653€ - 7 020 109€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare FUJIFILM HEALTHCARE FRANCE SAS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about FUJIFILM HEALTHCARE FRANCE SAS

What is the revenue of FUJIFILM HEALTHCARE FRANCE SAS ?

The revenue of FUJIFILM HEALTHCARE FRANCE SAS in 2025 is 122.1 M€.

Is FUJIFILM HEALTHCARE FRANCE SAS profitable?

Yes, FUJIFILM HEALTHCARE FRANCE SAS generated a net profit of 2.3 M€ in 2025.

Where is the headquarters of FUJIFILM HEALTHCARE FRANCE SAS ?

The headquarters of FUJIFILM HEALTHCARE FRANCE SAS is located in ASNIERES-SUR-SEINE (92600), in the department Hauts-de-Seine.

Where to find the tax return of FUJIFILM HEALTHCARE FRANCE SAS ?

The tax return of FUJIFILM HEALTHCARE FRANCE SAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does FUJIFILM HEALTHCARE FRANCE SAS operate?

FUJIFILM HEALTHCARE FRANCE SAS operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.